Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/INF.0000000000002418 | DOI Listing |
Publication Analysis
Top Keywords
invasive aspergillosis
12
liver failure
8
pediatric patient
8
isavuconazole-induced acute
4
acute liver
4
failure pediatric
4
patient invasive
4
aspergillosis isavuconazole
4
isavuconazole azole
4
azole approved
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!